Shukra Pharmaceuticals bulk deals
NSE: SHUKRAPHARBSE: 524632Pharmaceuticals & BiotechnologySmall Cap
Shukra Pharmaceuticals Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1994 on BSE, Aug 2026 on NSE
Last close ₹74.87down ₹0.19 (0.25%)BSE ₹74.95
Share price at the NSE close on 30 Oct 2026. Previous close ₹75.06.
30 Oct: open ₹75.84, high ₹77.11, low ₹74.60
52-week range of BSE trades to 30 Oct 2026
₹26.30Low, 27 May 2026₹79.90High, 29 Oct 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,291 Cr1,258th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 91.31
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 36.63
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.01%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 47.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 47.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.06
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 92,73,24821.1% delivered
Shukra Pharmaceuticals bulk deals
Last 12 months, since 30 Oct 2025: 10 bulk deals, ₹107 Cr bought and ₹106 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 29 Oct 20261 firm · ₹21 Cr bought · ₹21 Cr soldNet bought ₹0.04 Cr
- Both waysQE SECURITIES LLPBought 26,99,471 at ₹76.33Sold 26,92,287 at ₹76.400.61% of the companyNet +7,184 shares₹21 Cr bought
Friday 23 Oct 20261 firm · ₹19 Cr bought · ₹20 Cr soldNet sold ₹0.65 Cr
- Both waysHRTI PRIVATE LIMITEDBought 33,69,454 at ₹56.81Sold 34,27,223 at ₹57.740.78% of the companyNet −57,769 shares₹19 Cr bought
Monday 5 Oct 20263 firms · ₹67 Cr bought · ₹66 Cr soldNet bought ₹1.64 Cr
- Both waysHRTI PRIVATE LIMITEDBought 37,00,565 at ₹69.23Sold 33,95,277 at ₹69.190.85% of the companyNet +3,05,288 shares₹26 Cr bought
- Both waysQE SECURITIES LLPBought 31,07,889 at ₹68.78Sold 31,62,310 at ₹69.100.72% of the companyNet −54,421 shares₹21 Cr bought
- Both waysALPHAGREP SECURITIES PRIVATE LIMITEDBought 29,60,423 at ₹68.63Sold 29,60,423 at ₹68.670.68% of the companyNet nil₹20 Cr bought
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 10 deals on record from 4 Jan 2004.